Johnson & Johnson’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Johnson & Johnson’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,670,516	Closed	-$78.3M	–	24
2024 Q1	$78.3M	Hold	3,670,516	–	–	1.77%	2
2023 Q4	$35.3M	Hold	3,670,516	–	–	0.8%	7
2023 Q3	$9.54M	Hold	3,670,516	–	–	3.52%	8
2023 Q2	$17.1M	Hold	3,670,516	–	–	5.32%	6
2023 Q1	$13.8M	Hold	3,670,516	–	–	4.5%	7
2022 Q4	$11.6M	Hold	3,670,516	–	–	3.36%	8
2022 Q3	$11M	Hold	3,670,516	–	–	3.25%	9
2022 Q2	$9.14M	Hold	3,670,516	–	–	2.33%	11
2022 Q1	$28.5M	Hold	3,670,516	–	–	5.39%	8
2021 Q4	$15.3M	Hold	3,670,516	–	–	1.74%	10
2021 Q3	$29.1M	Buy	+3,670,516	New	+$30.9M	2.55%	10

Johnson & Johnson's FUSN Position: Q2 2024 in Review

Johnson & Johnson sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 3,670,516 shares — an estimated $78.3M sold.

Johnson & Johnson first reported a position in FUSN in Q3 2021 and held it in 11 quarters. The position peaked at $78.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Johnson & Johnson reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Johnson & Johnson sold 3,670,516 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $78.3M.
Johnson & Johnson first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2021 and held it in 11 quarters.
Johnson & Johnson's Fusion Pharmaceuticals Inc. Common Shares position peaked at $78.3M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Johnson & Johnson's 13F filing for Q2 2024, filed 9 Aug 2024.